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Summary 
The identification, in the late 2000’s, of innate lymphoid cells (ILCs) as a new class of non-B, 
non-T lymphocytes has led to global efforts to understand their functions, plasticity, and 
evolutionary origins and to define their place within the leukocyte family.  Although this work 
has uncovered striking similarities in the developmental cues, lineage-specific transcription 
factors and functional capacities of innate and adaptive lymphocytes, it has become clear 
that ILCs play a unique and defining role as stewards of barrier defence and that this sets 
them apart from their adaptive cousins.  This review will explore how the dynamic 
environment of barrier surfaces has shaped ILC evolution and functionality.  We highlight the 
critical importance of the microbiome and the unique role of ILCs as environmental sensors.  
We reflect on how these factors may have influenced the development of ILC2s and barrier 
immunity in the context of exposure to helminth parasites that have been driving forces of 
our evolution throughout human history.  Finally, we argue that the plasticity of ILC function 
reflects their role as first-responders to environmental change. 
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1. Introduction 
The groundbreaking discovery of lymphoid and myeloid cells as distinct leukocyte subsets 
with complementary functions has formed the basis for introductory immunology lectures for 
first year undergraduate students for over a century.  The pleasingly simple notion of myeloid 
cells with innate functions supported by lymphoid cells providing immune memory was 
complicated by the discovery first of Natural Killer (NK) cells, lymphoid cells capable of 
cytotoxic effector function without prior immunization (1), and later of lymphoid tissue inducer 
(LTi) cells that play key roles in the development of the architecture of the lymphatics (2).  
More recently, the discovery of three independent, but related, classes of non-B, non-T 
lymphocytes lacking antigen specificity and with innate functions (3) has led to a new 
appreciation for the wide-ranging roles played by the various lymphocyte subsets in diverse 
processes including defence against bacterial (4), viral (5) and parasitic infection (6), 
maintenance of barrier function (7), wound healing (8), repair (5), maintenance of metabolic 
homeostasis (9) and environmental sensing (7).  The discovery of the innate lymphoid cell 
(ILC) 1, 2, and 3 subsets has led to questions about the relationship of each class to one 
another and to the other innate and adaptive lymphocytes and has sparked interest in the 
evolutionary factors shaping the development of the lymphoid lineage. 
 
1.1. ILC subsets and functions 
ILCs can be found in lymphoid and non-lymphoid tissue but are particularly abundant at 
mucosal and non-mucosal barriers (10, 11).  From here they act as central coordinators for 
immune responses, integrating signals from the milieu, relayed via the epithelium, resident 
immune cells, the microbiome, pathogens or by sensing of the local availability of nutrients.  
ILC1, expressing the T-box transcription factor T-bet, produce IFN-γ and contribute to 
defence against bacterial and protozoan infection (12-14). ILC2, expressing GATA-binding 
protein 3 (GATA-3) (15) and RAR-related orphan receptor alpha (ROR-α) (16), produce the 
canonical type 2 cytokine IL-4, IL-5, IL-9 and IL-13 and are instrumental in responses to 
helminth infection (6, 17, 18), as well as coordinating tissue repair(5) and maintaining 
metabolic homeostasis (9). ILC3, expressing ROR-γt, produce IL-17A and IL-22(19, 20) and 
contribute to both antibacterial immunity (21) and tissue homeostasis (22).   
This review aims to put ILCs in the context of the ever-changing environment of barrier 
surfaces where dietary signals, microbiome interactions and pathogen exposure shape 
immune responses.  A major focus will be ILC2 cells and an exploration of how their anti-
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helminthic functions overlap with their roles as environmental sensors, but where useful we 
will draw on studies of other ILC subsets. 
 
1.2. ILC2 and helminth infection 
ILC2s had initially been referred to as a non-B non-T-cell (NBNT) that relied upon IL-25 for 
survival and activation (23). Deletion of IL-25 or its receptor IL-25R (IL-17E-R) resulted in an 
absence of these cells and thus loss of protective responses to infection with 
Nippostrongylus brasilensis. Thereafter, a series of papers published in 2010 described IL-
13-producing innate lymphoid cells in the mouse (6, 17, 18). The papers characterized the 
cells in different biological systems and the three identified populations were initially given 
different names, although all have since been grouped in the ILC2 family (3). ILC2 produce 
type 2 cytokines in response to local cues, including the alarmin cytokines IL-25 and IL-33 
(6).  The role of ILC2 in defence against helminth infection is multifaceted and mediated 
through production of type 2 cytokines and also by direct interactions with T cells.  Via 
production of IL-5 and IL-13, ILC2 contribute to key anti-helminthic functions including 
eosinophilia (24) and goblet cell hyperplasia (6, 17). The parasite clearance defect in 
Nippostrongylus brasiliensis-infected mice lacking IL-25 and IL-33 receptors can be reversed 
by adoptive transfer of IL-13-producing ILC2 (6). Importantly, IL-25 administration alone 
does not induce worm expulsion in T- and B-cell deficient rag2-/-γc-/- mice in the absence of 
ILC2s (18), identifying ILC2 as the key IL-25-responsive cell in N. brasiliensis infection.   
ILC2 play a further role in helminth infection via interaction with Th2 cells (25).  MHCII-
expressing ILC2s interact with antigen-specific T cells that in turn produce IL-2 to encourage 
ILC2 proliferation and type 2 cytokine production. Deletion of ILC2 MHCII attenuates the 
ability of ILC2 to stimulate N. brasiliensis expulsion, highlighting the importance of ILC2-T 
cell crosstalk.  
 
1.3. ILCs at barrier surfaces 
The relative enrichment of ILCs at barrier sites such as the lung and intestines reflects their 
key roles as modulators of the host-environment interface, as ‘first responders’ in the event 
of infection and as supporters of dendritic cells in the development of adaptive immune 
responses .  The following sections will explore how ILC function at barrier surfaces may 
have evolved to serve these purposes. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
1.4. ILCs and the microbiome 
The last decade has seen an explosion in research into the role of the human microbiome in 
health and disease.  The respiratory and intestinal tracts, and the skin are home to complex 
microbial communities and are also major sites of ILC activity, and it has become apparent 
that sensing changes in these microbial communities is a key function of ILCs – perhaps to 
prepare the host environment in advance of infection.  Much of the attention is this area has 
been given to ILC3 and this work has led to some important emerging concepts. New 
evidence suggests that analogous processes may shape ILC2 responses at the interface 
with microbial populations. 
The ILC3-derived cytokines IL-17A and IL-22 have potent tissue protective effects via 
coordination of defence against extracellular bacteria (26) and promotion of tissue repair 
(27).  By contrast, excessive or uncontrolled production of these cytokines by ILC3 has been 
linked with inflammatory diseases of the bowel (19) and skin (28), and ILC3 GM-CSF 
production has been associated with acute intestinal inflammation (29).  ILC3-derived IL-17A 
sustains inflammation in models of innate inflammatory bowel disease (19, 30) and IL-17A-
producing ILC3s accumulate in the inflamed gut of Crohn’s disease patients (19, 31). The 
regulation of ILC3 functionality at the barrier surface is therefore key to health.  
The microbiome, and microbial products, play a major role in the regulation of intestinal IL-22 
production (32) and, in turn, IL-22 supports intestinal barrier integrity, preventing 
dissemination of commensal flora (33).  IL-22-deficient mice are highly susceptible to 
disease caused by the attaching and effacing bacterial pathogen Citrobacter rodentium and 
infection is associated with a loss of colonic epithelial cell integrity and results in systemic 
bacterial spread (33). Similarly, commensal Alcaligenes species residing in lymphoid tissues 
are restricted to this niche by LTi-derived IL-22, thus preventing systemic inflammation (32, 
34). IL-22-producing T helper cells (Th22) play an important role in late-stage C. rodentium 
infection but it is not clear whether, as the predominant intestinal IL-22-producers, ILC3s are 
also involved. Indeed, recent findings suggest that, in the presence of T cells, IL-22-
producing NKp46+ ILC3 are dispensable for control of C. rodentium infection but are 
required for protection of the cecum (22).  
Further intimate links between microbiome and ILCs are highlighted by the finding that ILC3 
expand and produce IL-22 in response to alterations in the microbiota following dextran 
sodium sulfate administration, and this response is concomitant with a return to normal 
barrier function (35). A recent study by Gury-Ben Ari and colleagues reveals the complexity 
of microbiome-induced regulation of ILC functions (36). RNA-seq and ChIP-seq analysis of 
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ILC subsets from Germ-free and antibiotic-treated mice revealed altered profiles for 
hundreds of transcripts and a markedly altered chromatin landscape relative to mice with 
undisturbed intestinal microbial communities.  ILC1 and ILC2 were notably more affected by 
these microbial changes than ILC3 and adopted a transcriptional signature similar to that of 
ILC3. This work builds on the previous insights of Sawa et al. regarding ILC3 expansion 
following microbiome depletion (35), and suggests that a steady state microbiome may 
inhibit ILC3-associated transcriptional signatures in intestinal ILC populations. Upon 
microbiome depletion, release of this inhibition allows ILC3 to expand and maintain barrier 
function. The alterations in the chromatin landscape in antibiotic-treated mice described by 
Gury-Ben Ari et al. took place over just a few weeks, demonstrating that ILCs can read the 
state of microbial colonization and rapidly adjust their activity accordingly, via changes in the 
enhancer landscape and transcription-factor binding site accessibility. These epigenetic 
changes are in line with the emerging concept of learned immunity that is being recognized 
as critical in determining specificity in innate immune responses (37).  
A groundbreaking recent paper has described how helminth infection can alter the 
composition of the intestinal microbiome (38).  Mice deficient in the Crohn’s disease 
susceptibility gene Nod2 develop abnormalities in the small intestine that are driven by 
Bacteroides vulgatus, a constituent of the gut microbiota (39).  Mice infected with the 
roundworm Trichuris muris are resistant to Bacteroides colonisation and accordingly do not 
develop intestinal abnormalities (38).  T. muris-induced changes in intestinal microbiota are 
transitory and reverse in the weeks following clearance of infection (40). Crucially, 
administration of recombinant IL-13 or IL-4 to Nod2-/- mice reproduced the effect of helminth 
infection (38), demonstrating that colonisation resistance is the result of induction of type 2 
immunity.  The contribution of ILC2s to colonisation resistance has not been assessed, but 
as a major source of intestinal type 2 cytokine they have potential to play a key role.  Indeed, 
the ability of IL-13 and IL-22 – key ILC2 and ILC3 cytokines respectively - to drive goblet cell 
hyperproliferation and mucus production during helminth infection (41, 42) is likely to 
influence bacterial colonisation of the intestine (43).  Furthermore, Zaiss and colleagues 
have demonstrated that the ability of helminth infection to modulate allergic asthma is 
dependent upon changes in the intestinal microbiome and, particularly an increase in 
Clostridiales species that produce short chain fatty acids (44).  Given the importance of fatty 
acid metabolism to ILC2 function (45) (discussed in section 1.6. below) this may point to an 
intriguing interplay between helminths, ILC2s and the microbiome, with ILC2 finely tuning 
their function to the linked changes in helminth infection status and composition of the 
microbiome.  
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ILC3 possess an analogous mechanism to sense and control the microbial environment via 
IL-22 production linked to lipid antigen engagement of surface-expressed CD1d (46).  
Antibody-mediated cross-linking of CD1d on ILC3 is sufficient to induce an IL-22 response, 
but engagement of CD1d also acts synergistically with IL-23 to further enhance IL-22 
production. IL-22 plays a central role in epithelial barrier function and tissue repair and thus, 
ILC3 integration of signals obtained through CD1d, along with those received from cytokines 
in the local inflammatory milieu, may contribute to maintenance of homeostasis and to 
regulation of immune responses.  Environmental sensing via recognition of microbial-derived 
lipids through CD1d likely contributes to maintenance of barrier function by ILC3. The 
influence of lipids and lipid metabolism on the function of both ILC2 (45) and ILC3 (46) 
suggests that environmental sensing is a core and conserved function of ILCs lineages.     
It is clear, therefore, that a major role for ILCs in the intestine is the maintenance of barrier 
homeostasis.  This is maintained both by microbe-mediated changes in ILC effector function 
and by ILC-driven changes in the composition of the microbiota. Maintaining the vast and 
complex microbial communities within the intestine requires a delicate balance between 
promotion and inhibition of immune responses directed against the microbiota.  This is 
evidenced by the existence of functionally discrete ILC3 subsets, including those that 
present antigen and inhibit microbiota-directed T cell immunity (47) and those that promote 
anti-microbiota T cell responses via IL-22 production (48). 
 
1.5. ILC2 and nutrient sensing 
Just as ILC2 and ILC3 acquire signals from the microbiota that help shape their function, so 
ILC2 utilise nutritional sensing to adapt to changes at barrier surfaces. ILC2s are particularly 
adept at responding to dietary changes, tailoring immune responses accordingly.  This 
nutritional sensing is intimately intertwined with the key role of ILC2 in defence against 
helminth infection.  
Parasitic infections, particularly gastrointestinal nematodes, can have a significant impact on 
host nutrition and contribute to macro- and micronutrient deficiencies.  Malnutrition is the 
predominant cause of immunosuppression worldwide (49), and is particularly common in 
areas where soil-transmitted helminth infection is endemic (50, 51).   More than three 
quarters of the countries with moderate or severe vitamin A deficiency in children are also 
considered by the World Health Organisation to be at risk of soil-transmitted helminth 
infection and in need of periodic preventive chemotherapy (52); this represents some 250 
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million children. It is notable, therefore, that a recent cross-sectional study of pre-school and 
school-age children in urban slums in Nairobi, Kenya found significant associations between 
soil-transmitted helminth infection in pre-school children and both vitamin A and iron 
deficiencies (53).  However, identifying a cause and effect relationship between infection and 
macro- and micronutrient deficiencies has not been straightforward. Interventional studies, 
including randomized-controlled trials utilizing vitamin A supplementation in combination with 
deworming, have failed to show significant benefits on serum retinol levels (54, 55). Meta-
analyses have further exposed the complexity of the interaction between infection and 
malnutrition. One review encompassing experimental and observational studies of soil-
transmitted helminths, schistosomiasis and a number of micronutrient measures identified no 
effect of antihelminthic treatment on vitamin A status but did describe a negative association 
between helminth infection and serum retinol (56).      
Mechanistic understanding of the relationship between infection and nutrient deficiencies is 
also lacking, but it is likely that reduced appetite (57), impaired nutrient absorption following 
helminth-induced tissue damage (58) and increased nutrient loss all play a role (59).  With 
regards to vitamin A deficiencies, helminths including Ascaris lumbricoides express retinol 
and retinoic acid-binding and degrading proteins that they utilize for their growth and 
development (60).  Retinoic acid is highly enriched in the gastrointestinal tract and is key to a 
functioning adaptive immune system (61-63).  T helper cell subsets are notably reduced in 
the gastrointestinal tract of vitamin A deficient mice (62, 64). 
ILC play a key role in sensing such infection-induced changes in host nutritional status or 
metabolism and tailoring immune responses accordingly.  Spencer and colleagues have 
described the relative enrichment of intestinal ILC2s in vitamin-A deficient mice and the 
corresponding reduction in ILC3 populations (7).  ILC3 and ILC3-derived IL-22 and IL-17A 
were substantially reduced in vitamin A deficient mice, alongside increases in ILC2 and 
ILC2-derived IL-4, IL-5 and IL-13.  This effect could be reproduced by inhibition of retinoic 
acid signaling in wild type animals and reversed by retinoic acid treatment of vitamin A 
deficient mice.  These processes occurred independently of commensal bacterial flora, 
suggesting a different mechanism of environmental sensing to that utilized by ILC3 to 
respond to changes in intestinal flora.   
Retinoic acid has a cell-intrinsic suppressive role on ILC2 maturation (7). Addition of retinoic 
acid impairs ILC2 development from ILC2 common progenitors in culture and inhibition of 
retinoic acid signaling increases ILC2 development and cytokine production.  Common 
lymphoid progenitors transferred to ILC-deficient mice give rise to both ILC2 and ILC3 in the 
intestine but the balance can be switched towards dominant accumulation of ILC3 or ILC2 by 
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promotion or inhibition of retinoic acid signaling respectively.  The ILC2-ILC3 balance is of 
functional significance for intestinal health, as the relative impairment of ILC3 in vitamin A-
deficient mice or those treated with retinoic acid blockers was associated with increased 
susceptibility to infection with Citrobacter rodentium. 
Although retinoic acid appears unable to convert mature ILC2s into ILC3s, it does encourage 
IL-22 production from ILC3 and inhibit ILC2 responses, in part by reducing IL-7Rα 
expression on ILC2s and their progenitors.  Inhibition of retinoic acid reverses these effects 
and encourages increased IL-7 responsiveness in ILC2.  Thus, in conditions of vitamin A 
scarcity, innate type 2 immunity is enhanced at the intestinal barrier.  Heightened intestinal 
mucus production is evident in mice following vitamin A withdrawal (64) and vitamin A-
deficient mice undergo goblet cell hyperplasia and increased RELM-β production, driven by 
ILC2-derived IL-13. Retinoic acid inhibition in mice infected with Trichuris muris did not 
compromise control of infection, as the defective TH2 response was offset by increased IL-
13-producing ILC2s (7).  
Thus, vitamin A deficiency is associated both with resistance to nematode infection and 
increased susceptibility to bacterial infection.  Spencer and colleagues argue that this switch 
in immune priorities may provide a means of maintaining barrier immunity in the face of 
dietary challenge.  Vitamin A acts as a warning signal, allowing immunological adaptation to 
compensate for the impairment of adaptive immunity that is associated with retinoic acid 
scarcity.  By boosting innate type 2 immunity, barrier defence is maintained via increased 
mucus production, tissue repair and promotion of immunomodulatory responses (65). We 
may speculate that ILC2-driven defenses against helminths evolved in tandem with human 
development in resource poor settings; where the problems of chronic malnutrition and 
endemic helminth infection overlap. 
 
1.6. ILC2 and fatty acid metabolism 
The Belkaid lab have followed up their findings with a description of the metabolic changes 
within ILC2 that underpin their functional enhancement in vitamin A deficiency.  Building on 
previous work identifying the expression of genes associated with fatty acid metabolism as a 
key feature of ILC2s (66), Wilhelm et al. demonstrate that ILCs constitutively acquire fatty 
acids at barrier sites (45). This process is not essential for ILC maintenance, as blockade of 
fatty acid oxidation does not alter steady-state ILC numbers. However, blockade of fatty acid 
oxidation in the context of T. muris infection results in reduced ILC2 accumulation and 
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reduced infection-related increases in IL-5 and IL-13.  A similar reliance on fatty acid 
oxidation for immune cell function during helminth expulsion has previously been 
demonstrated for alternatively activated macrophages (67, 68). 
Mobilisation of fatty acids for use as an energy source is a physiological safety net in times 
of dietary restriction when glucose is scarce (69).  It appears that ILCs, particularly ILC2, 
also show an increased reliance on fatty acid oxidation in periods of nutritional shortage (45). 
The increased ILC2 functionality in vitamin A deficient or retinoic acid inhibitor treated mice 
is mediated through increased fatty acid acquisition, and reduced retinoic acid signaling 
induces transcriptional changes in ILC2 that reflect an increased reliance on fatty acid 
oxidation.  Intriguingly, blockade of fatty acid oxidation in vitamin A deficient mice reverses 
the usual enhancement of ILC2 IL-13 production afforded by reduced retinoic acid signaling 
but ILC2 IL-5 and IL-9 production is unaffected (45).  This finding lends further credence to 
the idea that ILC2 have evolved to selectively maintain IL-13 levels during times of dietary 
stress due to its unique barrier-protective properties. 
 
1.7. The role of brown adipose tissue in ILC2 function 
Brown adipose tissue (BAT) utilises energy stores and is responsible for the physiological 
response to cold (70), driving the use of fat stores in times of poor resources. In 2011, it was 
shown that IL-4-producing eosinophils were present in the fat tissues of normal mice, and 
those fed high fat diets harbored lower numbers of these cells (71). Moreover, transgenic 
mice overexpressing IL-5 had higher number of eosinophils infiltrating into the adipose tissue 
and the percentage of eosinophils was found to negatively correlate with the total body 
weight. The presence of these cells was directly responsible for the generation of 
alternatively activated macrophages within BAT. Macrophage recruitment was not altered in 
the absence of eosinophils but their activation was changed in animals lacking IL-4/IL-13. An 
extension of this work demonstrated that the presence of ILC2 cells was necessary for the 
initial production of IL-5 required to promote eosinophils (24). Moreover, the presence and 
function of ILC2 cells was responsive to caloric input and hormonal cues, e.g. leptin. The 
ILC2 population within adipose tissue was found to be responsive to IL-33 injection and their 
effects on adipose tissue were recapitulated upon experimental infection with N. brasiliensis. 
These findings suggest that BAT could be promoted and sustained via helminth infection, 
offering a plausible, albeit untested, mechanism for the low rates of metabolic syndromes in 
countries with high rates of helminth infection. Evidence underlying this can be gleaned from 
two earlier studies by McDermott et al and Worthington et al (72, 73). Experimental infection 
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with Trichinella spiralis was shown to increase the levels of cholecystokinin - a regulatory 
peptide decreasing food intake - at the peak of intestinal inflammation. Neutralisation of CD4 
T-cells resulted in food intake levels equivalent to pre-infection and a non-resolving parasite 
burden (72). Further work with T. spiralis has shown there to be a bi-phasic decrease in food 
intake coincident with the development of the adaptive immune response. Transfer of CD4 
T-cells was sufficient to restore the food intake changes in T- and B-cell deficient RAG-/- 
infected mice. The second phase of hypophagia was dependent upon TNF signaling causing 
a decrease in leptin. Artificial maintenance of pre-infection leptin levels resulted in delayed 
worm expulsion (73). Collectively, these studies demonstrate the intimate link between the 
resolution of parasite infection and the pre-existence or generation of a nutrient poor 
intestinal environment.  Key to this link is the ability of ILC2 to orchestrate anti-helminth 
immunity via tuning their responsiveness to their nutritional setting. 
 
1.8. Tuft cells and ILC2 
A further link between environmental sensing and ILC2 responses was recently put forward 
by three independent studies demonstrating the role of taste-chemosensory tuft cells (74) in 
driving the IL-25 dependent expansion of ILC2 cells in the intestine (75-77). von Moltke et al 
demonstrated that tuft cells in the intestinal epithelium constitutively express IL-25, thus 
sustaining ILC2s, and that N. brasiliensis infection drives tuft cell expansion and leads to a 
consequent rise in the number of ILC2s (77). Gerbe and colleagues further demonstrated 
that pou2f3-/- mice, lacking the Pou domain class 2 transcription factor 3, were deficient in 
tuft cells and thus lacked the IL-25 levels within the intestine required to maintain ILC2 
numbers. However, rIL-25 was sufficient to restore this defect, leading to worm clearance 
(75). A positive feedback loop whereby tuft cell derived IL-25 drives ILC2s and ILC2 derived 
IL-13 drives tuft cell expansion ensures amplification of type 2 immunity during helminth 
infection (76).  This response is reliant on signaling through the chemosensory receptor 
TRPM5 as trpm5-/- mice fail to expand tuft cells during Heligmosomoides polygyrus infection, 
do not increase tuft cell IL-25 production or ILC2 numbers and harbor higher parasite 
burdens than wild type controls (76). The question then arises; if tuft cells can sense 
invading helminths can they detect the metabolic or environmental cues that also give rise to 
ILC2?  At present, it is not clear whether tuft cells sense the local microbial environment of 
merely integrate signals from the mucosal immune system. 
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1.9. ILCs and dendritic cells 
In addition to providing a first line of defence against infection, innate immunity shapes the 
ensuing adaptive response via antigen presentation, costimulation and creation of an 
inflammatory milieu favouring differentiation of particular T helper cell subsets.  The role of 
ILCs in directing adaptive immunity is best described in the case of allergic airway 
inflammation, where it has been demonstrated that ILC2s are critical for robust T helper (Th) 
2 responses to the protease-allergen papain (78). Whilst IL-4 is dispensable for generation 
of papain-induced Th2 responses, ILC2-derived IL-13 is required to drive migration of lung 
dendritic cells to the draining lymph nodes where Th2 differentiation results.  More recently, 
an analogous role for ILC2 in directing Th2 memory responses in the lung has been 
described, whereby ILC2-derived IL-13 was shown to stimulate dendritic cell production of 
the Th2-recruiting chemokine CCL17 (79).  Upon rechallenge of papain-sensitised mice, Th2 
cell recruitment to lung was significantly compromised both in ILC2-deficient mice and in 
those lacking expression of IL-13Rα1 expression on dendritic cells.  The role of ILCs in 
coordination of adaptive immunity at the intestinal barrier is less well described, but it is 
notable that administration of IL-33 or IL-13 leads to an increase in intestinal CCL17+ 
dendritic cells and that the IL-33 effect is abrogated in ILC2-deficient mice (79).  Thus, the 
function of sentinel dendritic cells at barrier sites appears to be dependent upon ILC activity, 
providing a further example of the unique role played by ILCs in sensing environmental 
change and responding rapidly to shape local immune responses. 
 
2. Conclusions and future directions 
Collectively, the recent advances in our understanding of ILC2 biology at barrier surfaces 
paint a complex picture of integration of signals coming from pathogens, the microbiome, the 
epithelium and the local availability of nutrients (Figure 1). The evolution of our immune 
system has taken place in the context of repeated and sustained exposure to bacteria, 
viruses and parasites.  Strategies have developed to distinguish pathogens from 
commensals and to limit tissue pathology during infection.  In both cases, the barrier 
surfaces have been key battlegrounds, as they represent sites rich in commensal organisms 
and where tissue damage can quickly lead to systemic infection.  Furthermore, the barrier 
sites of the skin, and gastrointestinal and respiratory tracts are major interfaces with the 
environment, and thus offer the opportunity for immune surveillance of a rapidly changing 
resource pool.  Accordingly, immune cells such as ILCs that operate at barrier surfaces have 
evolved tools to adjust their function in response to fluctuations in their niche.  ILC3 sense 
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changes in the composition of the microbiota that promote or inhibit their effector functions, 
while ILC2 are uniquely sensitive to changes in nutritional status.  This ability may have 
evolved to enable compensatory immune function in conditions where competition between 
parasite and host leads to local nutritional deprivation. The capacity to boost ILC2 numbers 
and their activity in times of nutrient scarcity may provide three benefits, firstly as a 
compensatory mechanism for the impairment of adaptive immunity that occurs in low vitamin 
A settings (62), secondly to reinforce immunity against helminth parasites that compete with 
their host for nutrients, and finally to boost colonization resistance and prevent enteric 
bacterial infection.  Entwined with this is the need to minimize the impact of damage caused 
by the migration of large metazoan parasites through host tissues.  In this regard, it is 
notable that the boost to ILC2 responses in reduced vitamin A conditions is offset by a 
reduction in the numbers and effectiveness of ILC3s (7). As key producers of the 
inflammatory cytokines IL-17A and IL-22, their inhibition may reflect a prioritizing of tissue 
repair and wound healing responses.  The promotion of these processes without excessive 
compromise of defence against infection requires intimate communication between the 
inflammatory and tolerogenic arms of the immune system (65).  Indeed, the need to maintain 
a balance between immune defence and immune tolerance has been a driving force in the 
evolution of both helminths and their human hosts (80-83). As the field progresses, several 
key questions remain to be addressed. Mechanistically, do ILC2 integrate both helminth and 
nutritional cues simultaneously, and structurally are there any similarities in the molecules 
that act as these cues? A key translational question, requiring careful examination, is can 
these interactions be manipulated effectively to either boost resistance or enhance current 
chemotherapeutic efforts at parasite control?  The intimate links between diet and immunity 
offer potential for affordable, non-invasive therapies designed to tune our immune systems 
to particular challenges in a variety of environments.  This is an exciting emerging field of 
research, and consideration will need to be given to the role of ILC in any such intervention 
therapies. 
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